Arrowhead Research | Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
Heron Therapeutics USD 12.02M 20K 2025-09
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Ligand Pharmaceuticals USD 27.76M 1.72M 2025-09
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Novartis USD 4.56B 49M 2025-09
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xencor USD 10.83M 1.75M 2025-12


Arrowhead Research Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.